Creation and internal validation of a biopsy avoidance prediction tool to aid in the choice of diagnostic approach in patients with prostate cancer suspicion.
Urol Oncol. 2017 Aug 03;:
Nature. 2017 Aug 02;548(7665):66-69
Prostate Carcinoma with Amphicrine Features: Further Refining the Spectrum of Neuroendocrine Differentiation in Tumours of Primary Prostatic Origin?
Histopathology. 2017 Jul 30;:
Integrated Phenotypic/Genotypic Analysis of Papillary Renal Cell Carcinoma Subtypes: Identification of Prognostic Markers, Cancer-related Pathways, and Implications for Therapy.
Eur Urol Focus. 2016 Sep 22;:
Histopathology. 2017 Jul 19;:
Adv Anat Pathol. 2017 Jul;24(4):215-221
Modern-day prostate cancer is not meaningfully associated with lower urinary tract symptoms: Analysis of a propensity score-matched cohort.
Can Urol Assoc J. 2017 Jan-Feb;11(1-2):41-46
Arch Pathol Lab Med. 2017 Feb;141(2):182-183
Variant Histology and Clinicopathologic Features of Prostate Cancer in Men Aged <50 Years Treated with Radical Prostatectomy.
J Urol. 2017 Jan 24;:
Management of Small Renal Masses: American Society of Clinical Oncology Clinical Practice Guideline.
J Clin Oncol. 2017 Jan 17;:JCO2016699645